LOC390956 Inhibitors
LOC390956 inhibitors, based on the logical analysis of typical cellular signaling pathways, would encompass compounds that target various kinases and signaling molecules. For instance, staurosporine, a broad-spectrum kinase inhibitor, can lead to the inhibition of multiple downstream signaling pathways, which may be crucial for the activation, stabilization, or function of LOC390956. By inhibiting kinases upon which LOC390956 function may depend, staurosporine indirectly leads to its functional inhibition.
Furthermore, compounds such as LY294002 and wortmannin inhibit PI3K, preventing AKT activation. Since AKT is a central hub in cellular signaling, regulating cell growth, survival, and metabolism, the inhibition of this kinase could have widespread effects on associated pathways and proteins, including LOC390956. Similarly, if LOC390956 function relies on the MAPK/ERK pathway, the use of MEK inhibitors like U0126 and PD98059 would result in decreased ERK phosphorylation and activity, which could lead to the reduced functional activity of LOC390956.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent non-selective protein kinase inhibitor that can inhibit a broad range of kinases. Inhibition of key kinases can lead to suppression of downstream signaling pathways that may be crucial for LOC390956 activation or stabilization. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphatidylinositol 3-kinase (PI3K) inhibitor. By inhibiting PI3K, it prevents the activation of AKT, potentially reducing the phosphorylation and activity of downstream proteins that might interact with or regulate LOC390956. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can suppress the mTORC1 complex, which in turn could inhibit protein synthesis and cell growth pathways that LOC390956 may be involved in. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
A Hedgehog signaling pathway inhibitor that can block Smoothened (SMO) activity. If LOC390956 is part of the Hedgehog pathway, cyclopamine could reduce its functional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK1/2 inhibitor that impedes the MAPK/ERK pathway. By inhibiting MEK, downstream ERK activation is reduced, which could diminish the activity of proteins regulated by this pathway, potentially including LOC390956. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, which can decrease the activity of the p38 MAPK pathway. If LOC390956 is part of or regulated by this pathway, its activity would be indirectly diminished. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can suppress the JNK signaling pathway. If LOC390956 is associated with this pathway, inhibition of JNK activity could lead to reduced functional activity of LOC390956. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can lead to an accumulation of proteins destined for degradation. If LOC390956 is regulated by proteasomal degradation, bortezomib could indirectly inhibit its function by preventing its turnover. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR tyrosine kinase inhibitor that can prevent EGFR signaling. If LOC390956 is downstream of EGFR, its activity could be indirectly inhibited by gefitinib. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor which specifically blocks MEK1 activation, leading to decreased ERK phosphorylation. This could indirectly inhibit the function of LOC390956 if it is regulated by the ERK pathway. | ||||||